Google Could See Fix Based on UK Telecom Case as Way to Avoid Adtech Divestitures

Health Care Antitrust Weekly: TCF Launches Monthly Litigation and Investigations Tracker; Judge Rules in Teva Patent Case; Corcept at Risk of Losing Market Share, Per 2025 Formulary Design Changes

The Federal Trade Commission publishes second report on PBMs, focusing on how the Big Three PBMs markup specialty generic drug prices. The PBMs enjoyed excess revenues of $7.3 billion, the FTC wrote...

Dave: Company Voluntarily Eliminates Optional Tips and Express Fees for ExtraCash Product, Online Reviews Reveal Some Customers’ Negative View of New Fee Structure

The Department of Justice filed an amended complaint against Dave (DAVE) late last month, taking over the case from the Federal Trade Commission. The amended complaint seeks civil penalties and names...

Synopsys/Ansys: Deal Enters Phase 2 SAMR Review, but Could Face Complications from U.S.-China Trade Tensions

Synopsys’ (SNPS) proposed $35 billion buyout of Ansys (ANSS) last week entered an in-depth phase 2 merger review in China, as regulators start to ask market participants about the tie-up of the two...